GSK | ||
|---|---|---|
OUTLOOK RATING 1..100 | 76 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 5 Undervalued | |
PROFIT vs RISK RATING 1..100 | 51 | |
SMR RATING 1..100 | 34 | |
PRICE GROWTH RATING 1..100 | 58 | |
P/E GROWTH RATING 1..100 | 65 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| DTAN | GSK | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 86% | N/A |
| Stochastic ODDS (%) | 2 days ago 89% | 2 days ago 64% |
| Momentum ODDS (%) | 2 days ago 75% | 2 days ago 46% |
| MACD ODDS (%) | 2 days ago 74% | 2 days ago 55% |
| TrendWeek ODDS (%) | 2 days ago 75% | 2 days ago 53% |
| TrendMonth ODDS (%) | 2 days ago 61% | 2 days ago 51% |
| Advances ODDS (%) | 16 days ago 88% | 26 days ago 63% |
| Declines ODDS (%) | 26 days ago 70% | 5 days ago 54% |
| BollingerBands ODDS (%) | 2 days ago 79% | 2 days ago 70% |
| Aroon ODDS (%) | N/A | 2 days ago 43% |
A.I.dvisor tells us that DTAN and CON have been poorly correlated (+9% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DTAN and CON's prices will move in lockstep.
| Ticker / NAME | Correlation To DTAN | 1D Price Change % | ||
|---|---|---|---|---|
| DTAN | 100% | N/A | ||
| CON - DTAN | 9% Poorly correlated | +2.07% | ||
| TEAM - DTAN | 6% Poorly correlated | +0.07% | ||
| RAND - DTAN | 5% Poorly correlated | -0.47% | ||
| GSK - DTAN | 5% Poorly correlated | +0.02% | ||
| IDR - DTAN | 4% Poorly correlated | +1.05% | ||
More | ||||
A.I.dvisor indicates that over the last year, GSK has been loosely correlated with NVS. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if GSK jumps, then NVS could also see price increases.